Literature DB >> 22953598

New perspectives in the care of Parkinson disease.

Irving Asher1.   

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disorder. Since the initial description of PD, clinical evaluation and management has focused on the motor signs and symptoms. Recent advances in our knowledge of neurologic involvement has led to a new emphasis on a broad spectrum of clinical features prompting the development of guidelines by the American Academy of Neurology for ongoing care of patients with PD. This review will touch on the historical aspects and traditional management of PD and discuss the latest recommendations for evaluation and care of PD patients. A broadened understanding of the multisystem nature of PD will enable physicians to improve the care and quality of life of their patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22953598      PMCID: PMC6179771     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  23 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

Review 2.  Parkinson's disease psychosis 2010: a review article.

Authors:  Joseph H Friedman
Journal:  Parkinsonism Relat Disord       Date:  2010-06-09       Impact factor: 4.891

Review 3.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 4.  Milestones in Parkinson's disease therapeutics.

Authors:  Olivier Rascol; Andres Lozano; Matthew Stern; Werner Poewe
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

5.  The strong presence of REM sleep behavior disorder in PD: clinical and research implications.

Authors:  Carlos H Schenck; Bradley F Boeve
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

6.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

Review 7.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

Review 8.  Narcolepsy in Parkinson's disease.

Authors:  Imran Z Haq; Yogini Naidu; Prashanth Reddy; Kallol Ray Chaudhuri
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

9.  End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.

Authors:  Mark Stacy; Robert Hauser; Wolfgang Oertel; Anthony Schapira; Kapil Sethi; Fabrizio Stocchi; Eduardo Tolosa
Journal:  Clin Neuropharmacol       Date:  2006 Nov-Dec       Impact factor: 1.592

10.  Bowel movement frequency in late-life and incidental Lewy bodies.

Authors:  Robert D Abbott; G Webster Ross; Helen Petrovitch; Caroline M Tanner; Daron G Davis; Kamal H Masaki; Lenore J Launer; J David Curb; Lon R White
Journal:  Mov Disord       Date:  2007-08-15       Impact factor: 10.338

View more
  1 in total

1.  Cholesterol homeostasis: a key to prevent or slow down neurodegeneration.

Authors:  Laura Anchisi; Sandra Dessì; Alessandra Pani; Antonella Mandas
Journal:  Front Physiol       Date:  2013-01-04       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.